Elicio Therapeutics raises $15 million through a registered direct offering, according to multiple reports. The company offers shares to investors under a registered direct structure. One outlet reports the offering as a $15 million registered direct offering, while another notes that the stock declines around 5% as the transaction is priced. The reports indicate that the offering size is $15 million and that the pricing of the deal is associated with a near-term market reaction in the company’s shares. Both sources describe the same financing event and broadly align on the amount raised and the type of offering. Other operational details such as the number of shares, the purchase price, and the intended use of proceeds are not provided in the excerpts supplied, so they are not included here. The company’s announcement and subsequent market movement are the main points covered across the two outlets.